S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.07%) $0.927
USD/NOK
(0.15%) $10.86
USD/GBP
(0.03%) $0.792
USD/RUB
(-0.21%) $92.38

Realtime updates for Novartis AG [NVS]

Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturersā€”General
Last Updated28 Mar 2024 @ 16:00

0.89% $ 96.73

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz...

Stats
Today's Volume 1.52M
Average Volume 1.44M
Market Cap 189.25B
EPS $0 ( 2024-01-31 )
Next earnings date ( $1.720 ) 2024-04-23
Last Dividend $3.47 ( 2023-03-09 )
Next Dividend $0 ( N/A )
P/E 23.59
ATR14 $0.0280 (0.03%)

Volume Correlation

Long: -0.13 (neutral)
Short: -0.80 (moderate negative)
Signal:(26.229) Neutral

Novartis AG Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Novartis AG Correlation - Currency/Commodity

The country flag 0.08
( neutral )
The country flag 0.05
( neutral )
The country flag 0.00
( neutral )
The country flag -0.06
( neutral )
The country flag 0.00
( neutral )
The country flag -0.06
( neutral )

Novartis AG Financials

Annual 2023
Revenue: $46.66B
Gross Profit: $34.19B (73.27 %)
EPS: $7.15
Q4 2023
Revenue: $11.78B
Gross Profit: $8.75B (74.34 %)
EPS: $4.14
Q3 2023
Revenue: $12.09B
Gross Profit: $8.98B (74.22 %)
EPS: $0.850
Q2 2023
Revenue: $13.94B
Gross Profit: $9.60B (68.85 %)
EPS: $1.110

Financial Reports:

No articles found.

Novartis AG Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$3.47
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Novartis AG Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.41%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.966 2000-11-14
Last Dividend $3.47 2023-03-09
Next Dividend $0 N/A
Payout Date 2023-03-20
Next Payout Date N/A
# dividends 23 --
Total Paid Out $44.60 --
Avg. Dividend % Per Year 2.46% --
Score 4.3 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.17
Div. Directional Score 8.61 --
Next Divdend (Est)
(2025-01-10)
$3.62 Estimate 3.10 %
Dividend Stability
0.25 Very Poor
Dividend Score
4.30
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2000 $0.966 2.96%
2001 $0.450 1.12%
2002 $0.468 1.46%
2003 $0.627 1.89%
2004 $0.722 1.57%
2005 $0 0.00%
2006 $0.801 1.50%
2007 $0.969 1.67%
2008 $1.319 2.42%
2009 $1.541 3.11%
2010 $1.780 3.38%
2011 $2.11 3.56%
2012 $2.20 3.78%
2013 $2.27 3.56%
2014 $2.44 3.10%
2015 $2.52 2.73%
2016 $2.47 2.88%
2017 $2.46 3.38%
2018 $2.67 3.15%
2019 $2.57 3.06%
2020 $3.04 3.20%
2021 $3.38 3.58%
2022 $3.36 3.82%
2023 $3.47 3.76%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Royal 2023-10-30 Monthly 39 10.10% 8.50
GOF Dividend Royal 2023-11-14 Monthly 18 8.03% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2911.5004.186.27[0 - 0.5]
returnOnAssetsTTM0.1491.2005.056.06[0 - 0.3]
returnOnEquityTTM0.3151.5007.6110.00[0.1 - 1]
payoutRatioTTM0.498-1.0005.02-5.02[0 - 1]
currentRatioTTM1.1550.8009.227.38[1 - 3]
quickRatioTTM0.8840.8009.507.60[0.8 - 2.5]
cashRatioTTM0.5081.5008.2910.00[0.2 - 2]
debtRatioTTM0.264-1.5005.61-8.41[0 - 0.6]
interestCoverageTTM11.581.0006.826.82[3 - 30]
operatingCashFlowPerShareTTM7.052.007.6510.00[0 - 30]
freeCashFlowPerShareTTM5.622.007.1910.00[0 - 20]
debtEquityRatioTTM0.565-1.5007.74-10.00[0 - 2.5]
grossProfitMarginTTM0.7171.0001.3751.375[0.2 - 0.8]
operatingProfitMarginTTM0.1981.0008.038.03[0.1 - 0.6]
cashFlowToDebtRatioTTM0.5491.0008.068.06[0.2 - 2]
assetTurnoverTTM0.5100.8009.937.94[0.5 - 2]
Total Score12.05

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.351.0008.750[1 - 100]
returnOnEquityTTM0.3152.508.4710.00[0.1 - 1.5]
freeCashFlowPerShareTTM5.622.008.1310.00[0 - 30]
dividendYielPercentageTTM3.901.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM7.052.007.6510.00[0 - 30]
payoutRatioTTM0.4981.5005.02-5.02[0 - 1]
pegRatioTTM-3.091.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2831.0005.410[0.1 - 0.5]
Total Score5.17

Novartis AG

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators